Aclaris Therapeutics, Inc. - COM (ACRS)

Q2 2023 13F Holders as of 6/30/2023

Type / Class
Equity / COM
Number of holders
132
Total Shares
71M
Shares change
-501K
Total reported value, excl. options
$736M
Value change
+$5.84M
Put/Call ratio
1.21
Number of buys
65
Number of sells
-67
Price
$10.37
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.